Journals / Turkish Journal of Endocrinology and Metabolism / 2020 / Cilt: 24 - Sayı: 3

Spontan Feokromasitoma Rüptüründen Sonra Gelişen Trombotik Mikroanjiyopati: Nadir Bir MEN 2A Olgusu

Thrombotic Microangiopathy After Spontaneous Pheochromocytoma Rupture: A Rare MEN 2A Case

Pages
247–252
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Bu yazıda, MEN 2A'ya bağlı spontan feokromasitoma rüptürü sonrası hipertansif kriz ve trombotik mikroanjiyopati (TMA) gelişen erkek bir olgu sunmayı amaçladık.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Feokromasitoma, katekolamin üreten ve salgılayan kromaffin hücrelerden kaynaklanan adrenal medulla kaynaklı bir tümördür.
📊
Key Findings & Data:Bu tümörler genellikle sporadik olarak ortaya çıkar, ancak multipl endokrin neoplazi sendromu tip 2 (MEN2) gibi genetik hastalıklarla da ilişkili olabilir.
💡
Conclusion & Impact:Bu yazıda, MEN 2A'ya bağlı spontan feokromasitoma rüptürü sonrası hipertansif kriz ve trombotik mikroanjiyopati (TMA) gelişen erkek bir olgu sunmayı amaçladık.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Feokromasitoma, katekolamin üreten ve salgılayan kromaffin hücrelerden kaynaklanan adrenal medulla kaynaklı bir tümördür. Bu tümörler genellikle sporadik olarak ortaya çıkar, ancak multipl endokrin neoplazi sendromu tip 2 (MEN2) gibi genetik hastalıklarla da ilişkili olabilir. Spontan feokromasitoma rüptüründen sonra gelişen hipertansif kriz, nadir görülen ve mortalitesi yüksek olan klinik bir durumdur. Bu yazıda, MEN 2A'ya bağlı spontan feokromasitoma rüptürü sonrası hipertansif kriz ve trombotik mikroanjiyopati (TMA) gelişen erkek bir olgu sunmayı amaçladık.

Özet

Pheochromocytoma is an adrenal medulla-derived tumororiginating from the chromaffin cells that produce and secretecatecholamines. These tumors usually occur sporadically,but they may also be associated with genetic diseases,such as multiple endocrine neoplasia syndrome type 2 (MEN2). A hypertensive crisis that occurs after the spontaneousrupture of pheochromocytoma, is a rare clinical complicationwith a high mortality rate. In this article, we present a malecase who developed hypertensive crisis and thrombotic microangiopathy(TMA) after a spontaneous pheochromocytomarupture due to MEN 2A.

🔖

Cite This Article

ÇORDAN, İ., KOCABAŞ, M., YILMAZ, S., CAN, M., KARAKÖSE, M., BURGUCU, H. Ç., KULAKSIZOĞLU, M., KARAKURT, F. (2020). Spontan Feokromasitoma Rüptüründen Sonra Gelişen Trombotik Mikroanjiyopati: Nadir Bir MEN 2A Olgusu. Turkish Journal of Endocrinology and Metabolism, Cilt: 24 - Sayı: 3, 247–252. https://ajindex.com/articles/370738

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. DeLellis RA, Lloyd RV, Heitz PU, Eng C: Pathology and Genetics of Tumours of Endocrine Organs. 2004, IARC Press Lyon, France
  2. Stenström G, Svärdsudd K. Pheochromocytoma in Sweden 1958-1981. An analysis of the national cancer registry data. Acta Med Scand. 1986;220:225- 232. [Crossref] [PubMed] 3. Lenders JWM, Duh QY, Eisenhofer G, Gimenez- Roqueplo AP, Grebe SKG, Hassan Murad M, Naruse M, Pacak K, Young Jr WF, Endocrine Society: Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99:1915-1942. [Crossref] [PubMed] 4. Manger WM. The protean manifestations of pheochromocytoma. Horm Metab Res. 2009;41:658-663. [Crossref] [PubMed] 5. Zelinka T, Eisenhofer G, Pacak K. Pheochromocytoma as a catecholamine producing tumor: Implications for clinical practice. Stress. 2007;10: 195-203. [Crossref] [PubMed] 6. Young Jr WF, Maddox DE. Spells: in search of a cause. Mayo Clin Proc. 1995;70:757-765. [Crossref] [PubMed] 7. Takana K, Nogushi S, Shuin T, Kinoshita Y, Kubota Y, Hosaka M. Spontaneous rupture of adrenal pheochromocytoma: a case report. J Urol. 1994;151:120-121. [Crossref] [PubMed] 8. Benz K, Amann K.Thrombotic microangiopathy: new insights. Curr Opin Nephrol Hypertens. 2010;19:242-247. [Crossref] [PubMed] 9. Khanal N, Dahal S, Upadhyay S, Bhatt VR, Bierman PJ. Differentiating malignant hypertension-induced thrombotic microangiopathy from thrombotic thrombocytopenic purpura. Ther Adv Hematol. 2015;6:97-102. [Crossref] [PubMed] [PMC] 10.Manger W, Gifford RW. The clinical and experimental pheochromocytoma. Malden (MA): Blackwell Science, 1996. 11.Habib M, Tarazi I, Batta M. Arterial embolization for ruptured adrenal pheochromocytoma. Curr Oncol. 2010;17:65-70. [Crossref] [PubMed] [PMC] 12.George JN, Nester CM. Syndromes of thrombotic microangiopathy. N Engl J Med. 2014;6;371:1847- 1848. [Crossref] [PubMed] 13.Eskazan AE, Buyuktas D, Soysal T. Postoperative thrombotic thrombocytopenic purpura. Surg Today. 2015;45:8-16. [Crossref] [PubMed] 14.Tsai HM. The molecular biology of thrombotic microangiopathy. Kidney Int. 2006;70:16-23. [Crossref] [PubMed] [PMC] 15. Gillett MJ, Arenson RV, Yew MK, Thompson IJ, Irish AB. Diagnostic challenges associated with a complex case of cystic phaeochromocytoma presenting with malignant hypertension, microangiopathic haemolysis and acute renal failure. Nephrol Dial Transplant. 2005;20:1014. [Crossref] [PubMed] 16.Schweizer H, Boehm J, Winterer JT, Wild D, Neumann HP